|
ATP7A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8652600000002E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.410600E-04 |
| Normal-vs-Stage2 |
1.145220E-01 |
| Normal-vs-Stage3 |
3.36779999998704E-07 |
| Normal-vs-Stage4 |
2.61479999985603E-07 |
| Stage1-vs-Stage2 |
5.770200E-01 |
| Stage1-vs-Stage3 |
4.441500E-03 |
| Stage1-vs-Stage4 |
3.400300E-03 |
| Stage2-vs-Stage3 |
4.078200E-02 |
| Stage2-vs-Stage4 |
2.564200E-02 |
| Stage3-vs-Stage4 |
7.041800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.443000E-04 |
| Normal-vs-AfricanAmerican |
3.9435998910875E-10 |
| Normal-vs-Asian |
1.864430E-01 |
| Caucasian-vs-AfricanAmerican |
2.11379999999206E-05 |
| Caucasian-vs-Asian |
9.432800E-01 |
| AfricanAmerican-vs-Asian |
2.694400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.411010E-04 |
| Normal-vs-Female |
2.14610000004445E-06 |
| Male-vs-Female |
4.826400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.28509999997029E-06 |
| Normal-vs-Age(41-60Yrs) |
2.903600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.24810000001752E-06 |
| Normal-vs-Age(81-100Yrs) |
1.758640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.857000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.514100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.085600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.414200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.364200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.950000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.961000E-01 |
| Normal-vs-Grade 2 |
1.559250E-03 |
| Normal-vs-Grade 3 |
3.1631000000365E-06 |
| Normal-vs-Grade 4 |
2.61169996740307E-09 |
| Grade 1-vs-Grade 2 |
3.746200E-01 |
| Grade 1-vs-Grade 3 |
1.124430E-01 |
| Grade 1-vs-Grade 4 |
4.375400E-03 |
| Grade 2-vs-Grade 3 |
6.818300E-02 |
| Grade 2-vs-Grade 4 |
8.19539999999952E-05 |
| Grade 3-vs-Grade 4 |
6.495900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.175780E-02 |
| Normal-vs-ccB subtype |
5.569500E-04 |
| ccA subtype-vs-ccB subtype |
5.643600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.223220E-03 |
| Normal-vs-N1 |
4.774800E-04 |
| N0-vs-N1 |
1.063180E-01 |
|
|
